Family Legacy Inc. Makes New $1.15 Million Investment in Danaher Corporation $DHR

Family Legacy Inc. purchased a new stake in shares of Danaher Corporation (NYSE:DHR) during the second quarter, according to its most recent Form 13F filing with the Securities & Exchange Commission. The firm purchased 6,040 shares of the conglomerate’s stock, valued at approximately $1,150,000.

Other large investors have also made changes to their positions in the company. JPL Wealth Management LLC bought a new stake in Danaher during the 3rd quarter valued at approximately $25,000. Main Street Group LTD bought a new position in Danaher in the 1st quarter worth approximately $25,000. WFA of San Diego LLC bought a new position in Danaher in the 2nd quarter worth approximately $26,000. Elevated Capital Advisors LLC purchased a new stake in Danaher during the 4th quarter valued at approximately $26,000. Finally, Hilton Head Capital Partners LLC bought a new stake in shares of Danaher during the fourth quarter valued at approximately $27,000. 79.05% of the stock is currently owned by hedge funds and other institutional investors.

Analyst Ratings Changes

Several equities analysts have recently commented on DHR shares. Morgan Stanley lowered their target price on shares of Danaher from $270.00 to $255.00 and set an “overweight” rating on the stock in a report on Wednesday, April 22nd. Piper Sandler initiated coverage on shares of Danaher in a research note on Thursday, June 11th. They set a “neutral” rating and a $200.00 target price for the company. Evercore reiterated an “outperform” rating and issued a $230.00 price target on shares of Danaher in a report on Monday, July 6th. Royal Bank Of Canada increased their price objective on shares of Danaher from $200.00 to $215.00 and gave the company an “outperform” rating in a report on Wednesday, July 22nd. Finally, Stifel Nicolaus cut their price objective on Danaher from $260.00 to $220.00 and set a “buy” rating for the company in a research report on Wednesday, July 22nd. One analyst has rated the stock with a Strong Buy rating, nineteen have assigned a Buy rating and five have assigned a Hold rating to the company. According to data from MarketBeat.com, the stock has a consensus rating of “Moderate Buy” and a consensus price target of $228.91.

Danaher Trading Down 0.7%

Shares of DHR opened at $202.51 on Friday. The stock has a market capitalization of $142.37 billion, a PE ratio of 35.97, a P/E/G ratio of 2.52 and a beta of 0.78. The company’s fifty day moving average is $193.14 and its 200 day moving average is $193.21. The company has a debt-to-equity ratio of 0.48, a quick ratio of 1.25 and a current ratio of 1.65. Danaher Corporation has a fifty-two week low of $160.93 and a fifty-two week high of $242.80.

Danaher (NYSE:DHR) last released its quarterly earnings data on Monday, July 20th. The conglomerate reported $1.94 EPS for the quarter, beating the consensus estimate of $1.85 by $0.09. Danaher had a net margin of 15.95% and a return on equity of 11.04%. The business had revenue of $6.26 billion during the quarter, compared to analyst estimates of $6.12 billion. During the same quarter last year, the business earned $0.77 earnings per share. Danaher’s quarterly revenue was up 5.5% compared to the same quarter last year. Sell-side analysts expect that Danaher Corporation will post 8.53 earnings per share for the current fiscal year.

About Danaher

Danaher Corporation (NYSE: DHR) is a global science and technology company that designs, manufactures and markets products and services for the life sciences, diagnostics, and environmental and applied markets. The company organizes its operations into business segments focused on Life Sciences, Diagnostics, and Environmental & Applied Solutions, supplying instruments, reagents, software and related services that support research, clinical testing, biopharmaceutical development, and industrial and environmental monitoring.

Products and services in Danaher’s portfolio include analytical and diagnostic instruments, laboratory consumables and reagents, digital and software solutions for workflow and data management, field and industrial monitoring equipment, and service and maintenance programs.